Literature DB >> 22975751

Association of GWAS top hits with late-onset Alzheimer disease in Korean population.

Sun Ju Chung1, Jae-Hong Lee, Seong Yoon Kim, Sooyeoun You, Mi Jung Kim, Joo-Yong Lee, Jaeyoung Koh.   

Abstract

Recent genome-wide association studies (GWAS) have discovered several Alzheimer disease (AD) susceptibility loci. However, the identified susceptibility loci are substantially inconsistent across GWAS. We aimed to investigate the association of top associated variants in GWAS with AD in Korean population. We selected 86 single-nucleotide polymorphisms (SNPs) selected from 12 genes (ABCA7, APOE, BIN1, CD2AP, CD33, CLU, CR1, EPHA1, LRAT, MS4A6A, PCDH11X, and PICALM) and genotyped in 290 AD cases and 554 unrelated controls from the same region. Three SNPs [rs429358 in APOE: odds ratio (OR)=4.24, 95% confidence interval (CI)=3.01-5.96, P=1.23×10; rs2075650 in APOE: OR=3.57, 95% CI=2.51-5.06, P=1.23×10; and rs677909 in PICALM: OR=0.63, 95% CI=0.49-0.81, P=0.00036, log additive model] were significantly associated with AD susceptibility after correction for multiple testing. Six additional PICALM SNPs, 3 ABCA7 SNPs, and 1 APOE, CD33, and BIN1 SNPs each had significant uncorrected P values. There was no significant association for age at onset of AD. Our results confirm the association of PICALM gene (encoding phosphatidylinositol-binding protein) in addition to APOE gene with AD susceptibility in Korean population but did not show significant associations of other susceptibility loci with AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22975751     DOI: 10.1097/WAD.0b013e31826d7281

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  30 in total

1.  CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility.

Authors:  Towfique Raj; Katie J Ryan; Joseph M Replogle; Lori B Chibnik; Laura Rosenkrantz; Anna Tang; Katie Rothamel; Barbara E Stranger; David A Bennett; Denis A Evans; Philip L De Jager; Elizabeth M Bradshaw
Journal:  Hum Mol Genet       Date:  2013-12-30       Impact factor: 6.150

Review 2.  MS4A Cluster in Alzheimer's Disease.

Authors:  Jing Ma; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-07-01       Impact factor: 5.590

3.  CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations.

Authors:  Xingwang Li; Ning Shen; Shuyan Zhang; Jiafeng Liu; Qinghua Jiang; Mingzhi Liao; Rennan Feng; Liangcai Zhang; Guangyu Wang; Guoda Ma; Haihong Zhou; Zugen Chen; Yongshuai Jiang; Bin Zhao; Keshen Li; Guiyou Liu
Journal:  Mol Neurobiol       Date:  2014-09-04       Impact factor: 5.590

Review 4.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

5.  Association between CLU gene rs11136000 polymorphism and Alzheimer's disease: an updated meta-analysis.

Authors:  Ruixia Zhu; Xu Liu; Zhiyi He
Journal:  Neurol Sci       Date:  2018-02-02       Impact factor: 3.307

Review 6.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

7.  Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.

Authors:  Xi-Chen Zhu; Hui-Fu Wang; Teng Jiang; Huan Lu; Meng-Shan Tan; Chen-Chen Tan; Lin Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 8.  Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.

Authors:  Jens Pahnke; Oliver Langer; Markus Krohn
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

9.  The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations.

Authors:  Guiyou Liu; Haiyang Wang; Jiafeng Liu; Jingbo Li; Hali Li; Guoda Ma; Yongshuai Jiang; Zugen Chen; Bin Zhao; Keshen Li
Journal:  Neuromolecular Med       Date:  2013-07-28       Impact factor: 3.843

Review 10.  ABCA7 in Alzheimer's Disease.

Authors:  Qing-Fei Zhao; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.